Biocon Biologics reaches settlement with Amgen for Denosumab biosimilars commercialisation

House passes Biosecure Act, new Chinese biotech restrictions

DRRA56 minutes ago 0

From Ambition to Advantage: How Life Sciences Leaders Are Scaling AI

DRRA4 hours ago 0

Trade & Channel Strategies 2025: Channel Evolution Over the Last 20 Years

DRRA4 hours ago 0

FDA Approves Waskyra For Treatment of Wiskott-Aldrich Syndrome

DRRA5 hours ago 0